Susquehanna International Group’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.2K | Sell |
34,821
-22,258
| -39% | -$42.3K | ﹤0.01% | 5985 |
|
|
2025
Q1 | $405K | Sell |
57,079
-5,841
| -9% | -$41.4K | ﹤0.01% | 4617 |
|
|
2024
Q4 | $1.38M | Buy |
62,920
+57,160
| +992% | +$1.26M | ﹤0.01% | 2492 |
|
|
2024
Q3 | $116K | Buy |
5,760
+2,136
| +59% | +$42.9K | ﹤0.01% | 5067 |
|
|
2024
Q2 | $63.1K | Sell |
3,624
-13,132
| -78% | -$229K | ﹤0.01% | 5234 |
|
|
2024
Q1 | $699K | Buy |
16,756
+3,325
| +25% | +$139K | ﹤0.01% | 3075 |
|
|
2023
Q4 | $338K | Buy |
13,431
+9,924
| +283% | +$250K | ﹤0.01% | 4385 |
|
|
2023
Q3 | $115K | Sell |
3,507
-4,541
| -56% | -$148K | ﹤0.01% | 4863 |
|
|
2023
Q2 | $468K | Sell |
8,048
-1,370
| -15% | -$79.7K | ﹤0.01% | 3709 |
|
|
2023
Q1 | $246K | Buy |
+9,418
| New | +$246K | ﹤0.01% | 4645 |
|
|
2022
Q4 | – | Sell |
-5,020
| Closed | -$258K | – | 6853 |
|
|
2022
Q3 | $258K | Buy |
+5,020
| New | +$258K | ﹤0.01% | 4440 |
|
|
2022
Q2 | – | Sell |
-1,177
| Closed | -$62K | – | 6771 |
|
|
2022
Q1 | $62K | Sell |
1,177
-1,432
| -55% | -$75.4K | ﹤0.01% | 5266 |
|
|
2021
Q4 | $179K | Sell |
2,609
-1,992
| -43% | -$137K | ﹤0.01% | 5024 |
|
|
2021
Q3 | $730K | Buy |
4,601
+3,304
| +255% | +$524K | ﹤0.01% | 3184 |
|
|
2021
Q2 | $253K | Buy |
+1,297
| New | +$253K | ﹤0.01% | 4623 |
|
|
2019
Q4 | – | Sell |
-680
| Closed | -$259K | – | 4921 |
|
|
2019
Q3 | $259K | Buy |
680
+284
| +72% | +$108K | ﹤0.01% | 3592 |
|
|
2019
Q2 | $178K | Buy |
+396
| New | +$178K | ﹤0.01% | 3945 |
|